-
公开(公告)号:WO2023081840A1
公开(公告)日:2023-05-11
申请号:PCT/US2022/079324
申请日:2022-11-04
Applicant: FRONTIER MEDICINES CORPORATION
Inventor: PATEL, Snahel , TANAKA, Hiroko , ERLANSON, Daniel A. , GERKEN, Philip A. , WIDEN, John C. , WILLIAMS, Monika Jane , DOTSENKO, Irina
IPC: C07D471/04 , C07D487/04 , A61K31/519 , A61P35/00
Abstract: The present disclosure provides compounds and methods useful in the treatment and suppression of cancer, for example, useful for treating or suppressing cancers characterized by KRAS G12C. Also provided are pharmaceutical compositions containing such compounds and processes for preparing such compounds.
-
公开(公告)号:WO2023015237A1
公开(公告)日:2023-02-09
申请号:PCT/US2022/074512
申请日:2022-08-04
Applicant: FRONTIER MEDICINES CORPORATION
Inventor: ERLANSON, Daniel A. , WEBSTER, Kevin Richard
Abstract: The present disclosure relates generally to biological entity-protein (e.g. protein-protein) interactions for potential therapeutic applications, and more specifically to high- throughput methods for identifying bridging molecules that induce the formation of recruited biological entity-bridging molecule-target protein complexes to effect said biological entity-protein interactions. The present disclosure also provides methods for using said bridging molecules for treatment of disorders mediated by the target protein of the recruited biological entity-molecule-target protein complex.
-
3.
公开(公告)号:WO2022026726A1
公开(公告)日:2022-02-03
申请号:PCT/US2021/043724
申请日:2021-07-29
Applicant: FRONTIER MEDICINES CORPORATION
Inventor: DE OLIVEIRA, Saulo , HERMANN, Johannes , VARMA, Chris
Abstract: Techniques for characterizing protein candidate sites are provided. Experimental data comprising spectral data from an experimental data source is received. Based on the experimental data, a data set comprising a set of protein candidate sites within one or more proteins is created. For each protein candidate site of the set of protein candidate sites, a feature set characterizing the respective protein candidate site is generated. A characterization of the amenability for drug-discovery for one or more of the protein candidate sites is generated by applying a classifier to the respective feature set for the protein candidate site.
-
公开(公告)号:WO2021061858A1
公开(公告)日:2021-04-01
申请号:PCT/US2020/052322
申请日:2020-09-23
Applicant: FRONTIER MEDICINES CORPORATION
Inventor: SHAGHAFI, Michael B. , HERMANN, Johannes
IPC: C07K16/18 , C07K16/30 , C12Q1/6886
Abstract: Provided herein are methods and compounds for targeted autophagy.
-
5.
公开(公告)号:WO2022026723A2
公开(公告)日:2022-02-03
申请号:PCT/US2021/043721
申请日:2021-07-29
Applicant: FRONTIER MEDICINES CORPORATION
Inventor: DE OLIVEIRA, Saulo , HERMANN, Johannes , VARMA, Chris
IPC: G16B40/00 , G01N2500/04 , G16B15/30 , G16B45/00 , G16B50/30
Abstract: Techniques for characterizing protein candidate sites are provided. Experimental data comprising spectral data from an experimental data source is received. Based on the experimental data, a data set comprising a set of protein candidate sites within one or more proteins is created. For each protein candidate site of the set of protein candidate sites, a feature set characterizing the respective protein candidate site is generated. A characterization of the amenability for drug-discovery for one or more of the protein candidate sites is generated by applying a classifier to the respective feature set for the protein candidate site.
-
公开(公告)号:WO2019183600A1
公开(公告)日:2019-09-26
申请号:PCT/US2019/023753
申请日:2019-03-22
Inventor: NOMURA, Daniel, K. , ZONCU, Roberto , WARD, Carl , FUNG, Sin, Ki , VARMA, Chris, Kumar , FONTAINE, Benjamin
IPC: C07K16/18 , C07K16/30 , C12Q1/6886
Abstract: Provided herein, inter alia , are methods and compounds for targeted autophagy.
-
-
-
-
-